EN DE
STOCK COMPARISON

Sectra AB (publ) vs Abbott Laboratories: Fair Value & Quality

Both stocks run through our valuation models. Here is how Sectra AB (publ) (SECT-B) and Abbott Laboratories (ABT) compare, as of Aug 14, 2026.

As of Aug 14, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Sectra AB (publ) trades at SEK 278 versus a fair value of SEK 66.81 (-76%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).
Sectra AB (publ)
SECT-B.ST · SEK · Health Care
-76%
upside to fair value
overvalued
PriceSEK 278
Fair ValueSEK 66.81
Quality72/100
Abbott Laboratories
ABT · USD · Health Care
-33%
upside to fair value
overvalued
Price$111
Fair Value$74.79
Quality67/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Sectra AB (publ)Abbott Laboratories
Valuation
93.9×P/E (TTM)27.7×
14.53×P/S (TTM)3.89×
24.78×P/B3.36×
69.6×EV/EBITDA15.1×
PEG1.47×
0.5%Dividend yield
SEK 1.30Dividend per share
Profitability
15%Net margin14%
19%Operating margin13%
28%Return on equity12%
11%Return on assets6%
Growth
13%Revenue growth (YoY)8%
14.6%Avg. growth/yr (3Y)0.5%
16.8%Avg. growth/yr (5Y)5.1%
Balance & size
Debt / equity0.19×
$6BMarket cap$175B
healthyGrowth qualityhealthy

Sectra AB (publ) leads: 7 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Sectra AB (publ)of which business quality 73 · market factors 54 Abbott Laboratoriesof which business quality 66 · market factors 53
ProfitabilityMargins and returns on capital today
64
50
Quality GrowthAre margins and returns improving?
37
47
CashflowEarnings quality: real cash, not paper profit
98
71
Fin. StrengthBalance sheet, leverage, solvency risk
94
80
InvestmentDisciplined investing over empire-building
39
65
Low VolatilityCalm price path (market factor)
66
83
MomentumPrice trend over the last 3–12 months (market factor)
58
43
52W MomentumDistance to the 52-week high (market factor)
33
38
Net IssuanceBuybacks instead of dilution
82
84

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Sectra AB (publ)

DCF ModelsSEK 93.69
Earnings-BasedSEK 37.47
MultiplesSEK 62.65
Asset-BasedSEK 7.98
Growth DCFSEK 107
Economic ProfitSEK 35.87
Growth EarningsSEK 58.15

24 of 24 models see the stock below the current price.

Abbott Laboratories

DCF Models$73.01
Earnings-Based$29.42
Dividend Discount$39.73
Multiples$70.72
Asset-Based$20.05
Growth DCF$67.02
Economic Profit$37.49
Growth Earnings$70.25

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Sectra AB (publ)
Bear SEK 51.81Fair Value SEK 66.81Bull SEK 81.10
SEK 278 = current price (white tick)
Abbott Laboratories
Bear $51.13Fair Value $74.79Bull $94.43
$111 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Sectra AB (publ) · Health Care

Quality score72 · Top 25%
Fair value upside-76% · bottom 25%

Abbott Laboratories · Health Care

Quality score67 · Top 25%
Fair value upside-33% · below median

Bottom line

As of Aug 14, 2026, Fair Value Calculator sees Abbott Laboratories as the less overvalued of the two: Sectra AB (publ) trades at SEK 278 versus a fair value of SEK 66.81 (-76%), while Abbott Laboratories trades at $111 versus $74.79 (-33%).

Sectra AB (publ) has the higher quality score (72/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.